Spironolactone treatment for dermatologic indications is not associated with hypotension in a single-center retrospective study.
Academic Article
Overview
publication date
- February 21, 2024
published in
Identity
Digital Object Identifier (DOI)
- 10.1016/j.jaad.2024.01.057
PubMed ID
- 38483433